We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNNA:NASDAQHennessy Advisors, Inc. Analysis

Data as of 2026-04-08 - not real-time

$9.73

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Hennessy Advisors (HNNA) trades around $9.73, well below its 20‑day SMA of $9.69 and the 50‑day SMA of $9.91, indicating short‑term bearish pressure, but the MACD histogram has turned positive and the MACD signal is bullish, suggesting a potential bottoming. The stock’s RSI of 49 is neutral, and volume is on an increasing trend, providing modest confirmation of a possible reversal. Fundamentally, the company appears deeply undervalued with a trailing P/E of 8.46 versus an industry average of 16.82 and a price‑to‑book of 0.78, while its DCF fair value estimate exceeds $89 per share. Cash reserves of $71.9 M dwarf the modest $0.6 M debt, and free cash flow of $47.1 M supports a 6.17% dividend yield with a payout ratio under 50%, indicating dividend sustainability. Revenue has contracted 14% YoY, but margins remain solid (gross 55%, operating 31%, profit 27%) and ROE is near 9%, reflecting efficient capital use. The firm’s beta is low (≈0.4), implying limited market‑wide volatility, yet its 30‑day volatility is high at ~27%, pointing to company‑specific risk. With a market cap under $80 M and average daily volume well below its 10‑day average, liquidity is a concern, but the strong balance sheet and attractive yield make it appealing for income‑focused investors. Overall, the technical picture is mixed, but the valuation and cash profile favor a longer‑term upside thesis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price is near the identified support level of $9.29
  • Bearish SMA alignment (price below 20‑day and 50‑day SMAs)
  • Increasing volume suggests potential buying interest

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant undervaluation relative to peers (P/E 8.46 vs industry 16.82)
  • Strong cash position and sustainable high dividend yield
  • Low beta indicating limited market‑wide volatility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair‑value estimate far above current price, implying large upside
  • Consistent free cash flow generation supporting dividend growth
  • Stable business model focused on asset management with modest debt

Key Metrics & Analysis

Financial Health

Revenue Growth-14.30%
Profit Margin26.52%
P/E Ratio8.5
ROE9.42%
ROA4.76%
Debt/Equity0.61
P/B Ratio0.8
Op. Cash Flow$12.2M
Free Cash Flow$47.1M
Industry P/E16.8

Technical Analysis

TrendBearish
RSI49.2
Support$9.29
Resistance$10.06
MA 20$9.69
MA 50$9.91
MA 200$10.60
MACDBullish
VolumeIncreasing
Fear & Greed Index84.89

Valuation

Fair Value$89.23
GradeUndervalued
TypeValue
Dividend Yield6.17%

Risk Assessment

Beta0.39
Volatility26.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.